NasdaqGS:ILMNLife Sciences
Illumina Deepens Clinical Genomics Role With TruPath Genome And FSU Deal
Illumina (NasdaqGS:ILMN) has launched TruPath Genome, a whole genome offering focused on higher accuracy, efficiency, and resolving complex genomic regions.
The company is partnering with Florida State University's pediatric rare disease lab to provide clinical sequencing services for children with suspected rare conditions.
Together, these moves expand Illumina's presence in rare disease diagnostics and applied clinical genomics.
For investors watching genomics, Illumina remains a central...